It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Disrupted or atypical light–dark cycles disrupts synchronization of endogenous circadian clocks to the external environment; extensive circadian rhythm desynchrony promotes adverse health outcomes. Previous studies suggest that disrupted circadian rhythms promote neuroinflammation and neuronal damage post-ischemia in otherwise healthy mice, however, few studies to date have evaluated these health risks with aging. Because most strokes occur in aged individuals, we sought to identify whether, in addition to being a risk factor for poor ischemic outcome, circadian rhythm disruption can increase risk for vascular cognitive impairment and dementia (VCID). We hypothesized that repeated 6 h phase advances (chronic jet lag; CJL) for 8 weeks alters cerebrovascular architecture leading to increased cognitive impairments in aged mice. Female CJL mice displayed impaired spatial processing during a spontaneous alternation task and reduced acquisition during auditory-cued associative learning. Male CJL mice displayed impaired retention of the auditory-cued associative learning task 24 h following acquisition. CJL increased vascular tortuosity in the isocortex, associated with increased risk for vascular disease. These results demonstrate that CJL increased sex-specific cognitive impairments coinciding with structural changes to vasculature in the brain. We highlight that CJL may accelerate aged-related functional decline and could be a crucial target against disease progression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
2 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
3 West Virginia University, Department of Neuroscience, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, West Virginia University Cancer Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)